We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ALPHA:ATHEXAlpha Bank S.A. Analysis

Data as of 2026-07-08 - not real-time

$358.71

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Alphabet’s stock trades well above its discounted cash‑flow estimate, signaling a substantial premium that is reflected in a P/E nearly double the industry average and a price‑to‑book ratio in the high‑single digits. Technical signals are mixed: the price sits near the 20‑day SMA, RSI hovers around the neutral 50 mark, while a bullish MACD histogram and rising volume suggest short‑term momentum, yet the overall trend remains neutral. Recent news of an $85 billion equity raise—diluting shareholders by roughly 2 %—is being used to fund aggressive AI and cloud capex, a move praised by analysts who have upgraded the rating to strong buy. The company’s robust margins, strong cash generation, and low payout ratio underpin dividend sustainability, but high beta and 30‑day volatility point to notable price swings.
Given the overvalued pricing, elevated sector and regulatory risks, and the dilution impact, investors should weigh the growth upside from AI and cloud against the valuation gap. The balance sheet remains strong with ample cash and manageable debt, supporting long‑term confidence, while short‑term price pressure may persist as the market digests the equity issuance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Equity raise causing modest dilution
  • Neutral technical trend with bullish MACD histogram
  • Price premium relative to DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Accelerating AI and cloud investments funded by equity raise
  • Strong cash flow and low dividend payout ratio
  • Analyst upgrade to strong buy and robust earnings growth

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Dominant market position in search, advertising, and cloud
  • Sustainable dividend supported by high ROE and cash generation
  • Long‑term growth runway from AI‑driven services and diversified revenue streams

Key Metrics & Analysis

Financial Health

Revenue Growth21.80%
Profit Margin37.92%
P/E Ratio27.3
ROE38.88%
ROA14.64%
Debt/Equity20.03
P/B Ratio9.1
Op. Cash Flow$174.4B
Free Cash Flow$27.9B
Industry P/E15.9

Technical Analysis

TrendNeutral
RSI49.8
Support$333.69
Resistance$373.60
MA 20$356.04
MA 50$369.63
MA 200$317.24
MACDBullish
VolumeIncreasing
Fear & Greed Index91.25

Valuation

Fair Value$74.96
Target Price$428.54
Upside/Downside19.47%
GradeOvervalued
TypeGrowth
Dividend Yield0.24%

Risk Assessment

Beta1.33
Volatility33.70%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.